Stockholders’ Equity (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
Sep. 11, 2025 |
Sep. 05, 2025 |
Jun. 03, 2025 |
Jun. 03, 2024 |
Mar. 13, 2024 |
Feb. 08, 2024 |
Feb. 05, 2024 |
Jul. 14, 2023 |
Apr. 24, 2023 |
Feb. 29, 2024 |
Dec. 31, 2023 |
Sep. 30, 2023 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 07, 2025 |
Dec. 31, 2021 |
Sep. 10, 2021 |
Dec. 31, 2016 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000,000
|
200,000,000
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
10,000,000
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
| Number of shares issued, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 93,689,681
|
$ 15,520,354
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.10
|
|
|
|
|
|
| Exercise price per share of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
$ 13,565,760
|
|
|
|
|
|
|
|
$ 107,392,716
|
$ 15,946,078
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,394,440
|
1,572,176
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
$ 0.71
|
|
|
$ 1.32
|
$ 0.71
|
|
|
|
|
| Underwriting Agreement description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On
December 7, 2025, the Company entered into an underwriting agreement (the “ 2025 Underwriting Agreement”) with Morgan Stanley
& Co. LLC, as representative of the several underwriters named in Schedule 1 thereto (the “Underwriters”), relating to
the issuance and sale (the “2025 Offering”) of 19,117,646 shares of its common stock, par value $0.0001 per share (the “Shares”),
and pre-funded warrants to purchase 490,196 shares of its common stock (the “Pre-Funded Warrants”). The Shares are being
sold at a price of $5.10 per share and the Pre-Funded Warrants are being sold at a price of $5.09 per Pre-Funded Warrant, which represents
the per share offering price for the Shares minus the $0.01 per share exercise price for each Pre-Funded Warrant.
|
|
|
|
| PreFunded warrant effect description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i) the aggregate number of shares
of common stock beneficially owned by such holder (together with its affiliates) to exceed 4.99% of the total number of shares of common
stock outstanding immediately after giving effect to the exercise; or (ii) the combined voting power of the Company’s securities
beneficially owned by such holder (together with its affiliates) to exceed 4.99% of the combined voting power of all of the Company’s
securities immediately outstanding after giving effect to the exercise, as such percentage ownership is determined in accordance with
the terms of the Pre-Funded Warrant, which percentage may be changed at the holder’s election to a higher or lower percentage not
in excess of 19.99% upon at least 61 days’ notice to the Company.
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued upon exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
4,900
|
834
|
|
|
|
|
| Proceeds from stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,342
|
$ 2,489
|
|
|
|
|
| Stock based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,441,875
|
3,020,573
|
|
|
|
|
| Unrecognized stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,833,369
|
|
|
|
|
|
| Weighted-average vesting period |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 9 months 10 days
|
|
|
|
|
|
| Intrinsic value option vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,140,638
|
|
|
|
|
|
| Intrinsic value option outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
15,950,536
|
|
|
|
|
|
| Intrinsic value of options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,918
|
$ 3,069
|
|
|
|
|
| Non Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
198,000
|
198,000
|
|
|
|
|
| Options term |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.24
|
|
|
|
|
|
| Non Employees [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.48
|
|
|
|
|
|
|
| Non Employees [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.17
|
|
|
|
|
|
|
| Management of the Company [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
680,000
|
680,000
|
|
|
|
|
| Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
516,440
|
98,500
|
|
|
|
|
| Options term |
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
| Employees [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, lower range limit |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.20
|
|
|
|
|
|
| Employees [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, lower range limit |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.33
|
|
|
|
|
|
| Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recognized stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 402,163
|
|
|
|
|
| Unrecognized stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
| General And Administrative Expenses [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,690,671
|
1,404,044
|
|
|
|
|
| General And Administrative Expenses [Member] | Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recognized stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 242,454
|
$ 438,671
|
|
|
|
|
| 2016 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,761,120
|
|
417,120
|
| 2021 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
2,388,356
|
|
|
|
900,000
|
|
| Amended and Restated 2021 Omnibus Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock number of shares issued |
|
|
|
|
|
|
|
|
1,034,561
|
|
|
|
|
|
|
|
|
|
|
| Share price percentage |
|
|
|
|
|
|
|
|
5.00%
|
|
|
|
|
|
|
|
|
|
|
| Amended and Restated 2022 Omnibus Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock number of shares issued |
|
|
|
|
|
|
|
|
3,000,000
|
|
|
|
|
|
|
|
|
|
|
| Total number of shares reserve |
|
|
|
|
|
|
|
|
4,934,561
|
|
|
|
|
|
|
|
|
|
|
| Second Amended And Restated Nexcella 2022 Equity Incentive Plan [Member] | Equity Option [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,000
|
|
|
|
|
| Second Amended And Restated Nexcella 2022 Equity Incentive Plan [Member] | Equity Option [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
607,640
|
|
|
|
|
| Third Amended And Restated 2022 Equity Incentive Plan [Member] | Equity Option [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
607,640
|
|
|
|
|
| Third Amended And Restated 2022 Equity Incentive Plan [Member] | Equity Option [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
800,000
|
|
|
|
|
| Nexcella 2022 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
275,759
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,911
|
$ 632
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
19,117,646
|
6,319,025
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
783,970
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
275,759
|
|
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 26
|
|
|
|
|
|
| Number of shares issued upon exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
4,900
|
1,251
|
|
|
|
|
| Common Stock [Member] | Nexcella 2022 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,000
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
595,676
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
275,759
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of warrants |
2,936,709
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intrinsic value of warrants vested and outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 22,052,649
|
|
|
|
|
|
| Nexcella [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued upon exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nexcella [Member] | Equity Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recognized stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 148,319
|
|
|
|
|
| July ATM Sales Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued, value |
|
|
|
|
|
|
|
$ 4,200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of public offering |
|
|
|
|
|
|
|
$ 75,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
| Commission rate |
|
|
|
|
|
|
|
3.75%
|
|
|
|
|
|
|
|
|
|
|
|
| Deposit expense |
|
|
|
|
|
|
|
$ 15,000
|
|
|
|
|
|
|
|
|
|
|
|
| Legal fees |
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
|
|
|
|
| Cost fees and expense |
|
|
|
|
|
|
|
|
|
|
$ 10,000
|
$ 7,500
|
|
|
|
|
|
|
|
| June 2025 ATM Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued, value |
|
|
$ 50,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of public offering |
|
|
$ 75,000,000.0
|
$ 75,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Commission rate |
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other expenses |
|
|
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly reimbursement, amount |
|
|
3,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock value |
|
|
$ 13,450,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares sold, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,697,504
|
|
|
|
|
|
| Number of shares sold, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,409,430
|
|
|
|
|
|
| Underwriting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
|
|
5,535,055
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
$ 2.71
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share of common stock |
|
|
|
|
|
|
$ 2.5203
|
|
|
|
|
|
|
|
|
|
|
|
|
| Underwiring discounts and offering expenses |
|
|
|
|
|
|
$ 1,954,594
|
|
|
|
|
|
|
|
|
|
|
|
|
| Underwriting Agreement [Member] | Over-Allotment Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
783,970
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
2.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
$ 2.37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from private placement |
$ 9,300,000
|
$ 9,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreements [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
3,915,604
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Marketing Service Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124,443
|
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 357,376
|
|
|
|
|
| Marketing Service Agreement [Member] | July 25, 2023 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
120,571
|
114,767
|
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 270,000
|
$ 270,000
|
|
|
|
|
| Marketing Service Agreement [Member] | February 29, 2024 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
38,840
|
|
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 75,000
|
|
|
|
|
|
| Marketing Service Agreement [Member] | March 16, 2025 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 123,750
|
|
|
|
|
|
| Marketing Service Agreement [Member] | November Twenty Twenty Twenty Five [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
9,259
|
|
|
|
|
|
| Restricted common stock, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 40,000
|
|
|
|
|
|
| Marketing Services Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued upon exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
275,759
|
1,251
|
|
|
|
|
| Proceeds from stock options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,489
|
|
|
|
|
| Founders Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock issued |
|
|
|
|
238,220
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|